Victory Capital Management
NTGN

Victory Capital Management’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Victory Capital Management’s Portfolio NTGN Stock Details NTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,896
Closed -$12K – 3713
2020
Q1 		$12K Buy
+4,896
New +$8.03K ﹤0.01% 3281
2019
Q4 		– Sell
-2,397
Closed -$4K – 3681
2019
Q3 		$4K Buy
+2,397
New +$7.29K ﹤0.01% 3538

Victory Capital Management's NTGN Position: Q2 2020 in Review

Victory Capital Management sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q2 2020, closing a stake of 4,896 shares — an estimated $12K sold.

Victory Capital Management first reported a position in NTGN in Q3 2019 and held it in 2 quarters. The position peaked at $12K in Q1 2020. 0 funds tracked by Wall St. Rank hold NTGN as of Q2 2020.

  • Victory Capital Management reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 4,896 Neon Therapeutics, Inc. Common Stock shares in Q2 2020, an estimated $12K.
  • Victory Capital Management first reported a position in Neon Therapeutics, Inc. Common Stock in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Neon Therapeutics, Inc. Common Stock position peaked at $12K in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.